Basic concepts and methods for joint models of longitudinal and survival data

Journal of Clinical Oncology

Volumn 28, Issue 16, 2010, Pages 2796-2801

  Ibrahim, Joseph G ^a   Chu, Haitao ^a   Chen, Liddy M ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOXORUBICIN; PACLITAXEL;

BREAST CANCER; CANCER RELAPSE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISEASE MARKER; DISEASE SIMULATION; HUMAN; IMMUNE RESPONSE; JOINT MODEL; LONGITUDINAL STUDY; MEDICAL SOCIETY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SURVIVAL TIME; TREATMENT DURATION; TUMOR CELL; TUMOR IMMUNITY; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; MALE; MORTALITY; NEOPLASM; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SURVIVAL;

CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MODELS, STATISTICAL; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 77954944281     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.0654     Document Type: Review

References (31)

1. De Gruttola V, Tu XM: Modeling progression of CD4-lymphocyte count and its relationship to survival time. Biometrics 50:1003-1014, 1994
2. Tsiatis AA, DeGruttola V, Wulfsohn MS: Modeling the relationship of survival to longitudinal data measured with error: Applications to survival and CD4 counts in patients with AIDS. J Am Stat Assoc 90:27-37, 1995
3. Faucett CJ, Thomas CC: Simultaneously modelling censored survival data and repeatedly measured covariates: A Gibbs sampling approach. Stat Med 15:1663-1685, 1996
4. Faucett CJ, Schenker N, Taylor JMG: Survival analysis using auxiliary variables via multiple imputation, with applications to AIDS clinical trials data. Biometrics 58:37-47, 2002 (Pubitemid 34194486)
5. LaValley MP, DeGruttola V: Model for empirical Bayes estimators of longitudinal CD4 counts. Stat Med 15:2289-2305, 1996
6. Wulfsohn MS, Tsiatis AA: A joint model for survival and longitudinal data measured with error. Biometrics 53:330-339, 1997 (Pubitemid 27131905)
7. Pawitan Y, Self S: Modeling disease marker processes in AIDS. J Am Stat Assoc 83:719-726, 1993
8. Taylor JMG, Cumberland WG, Sy JP: A stochastic model for analysis of longitudinal AIDS data. J Am Stat Assoc 89:727-736, 1994
9. Brown ER, Ibrahim JG, DeGruttola V: A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics 61:64-73, 2005 (Pubitemid 40380965)
10. Wang Y, Taylor JMG: Jointly modelling longitudinal and event time data, with applications to AIDS studies. J Am Stat Assoc 96:895-905, 2001
11. Chi Y, Ibrahim JG: A new class of joint models for longitudinal and survival data accomodating zero and non-zero cure fractions: A case study of an International Breast Cancer Study Group trial. Stat Sin 17:445-462, 2007
12. Henderson R, Diggle P, Dobson A: Joint modelling of longitudinal measurements and event time data. Biostatistics 1:465-480, 2000 (Pubitemid 33213549)
13. Xu J, Zeger SL: Joint analysis of longitudinal data comprising repeated measures and times to events. Appl Stat 50:375-387, 2001 (Pubitemid 33399970)
14. Xu J, Zeger SL: The evaluation of multiple surrogate endpoints. Biometrics 57:81-87, 2001 (Pubitemid 32200140)
15. Song X, Davidian M, Tsiatis AA: An estimator for the proportional hazards model with multiple longitudinal covariates measured with error. Biostatistics 3:511-528, 2002 (Pubitemid 35431227)
16. Chi Y-Y, Ibrahim JG: Joint models for multivariate longitudinal and multivariate survival data. Biometrics 62:432-445, 2006 (Pubitemid 43926648)
17. Kirkwood JM, Ibrahim JG, Sondak VK, et al: The role of high-and low-dose interferon alfa-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 18:2444-2458, 2000 (Pubitemid 30415832)
18. Kirkwood JM, Ibrahim JG, Sosman JA, et al: High-dose interferon Alfa-2b significantly prolonged relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of intergroup trial E1694/S9512/C509801. J Clin Oncol 19:2370-2380, 2001 (Pubitemid 32391207)
19. Ibrahim JG, Chen M-H, Sinha D: Bayesian methods for joint modeling of longitudinal and survival data with applications to cancer vaccine studies. Stat Sin 14:863-883, 2004 (Pubitemid 39499216)
20. Brown ER, Ibrahim JG: A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. Biometrics 59:221-228, 2003 (Pubitemid 36750335)
21. Brown ER, Ibrahim JG: Bayesian approaches to joint cure rate and longitudinal models with applications to cancer vaccine trials. Biometrics 59:686-693, 2003 (Pubitemid 37093408)
22. M-H Chen, Ibrahim JG, Sinha D: A new joint model for longitudinal and survival data with a cure fraction. J Multivar Anal 91:18-34, 2004 (Pubitemid 39007498)
23. Schluchter MD: Methods for the analysis of informatively censored longitudinal data. Stat Med 11:1861-1870, 1992
24. Hogan JW, Laird NW: Model-based approaches to analyzing incomplete longitudinal and failure time data. Stat Med 16:239-257, 1997
25. Tsiatis AA, Davidian M: Joint modeling of longitudinal and time-to-event data: An overview. Stat Sin 14:809-834, 2004 (Pubitemid 39499214)
26. Ibrahim JG, Chen M-H, Sinha D: Bayesian Survival Analysis. New York, NY, Springer-Verlag, 2001
27. Law NJ, Taylor JMG, Sandler H: The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. Biostatistics 3:547-563, 2002
28. Hsieh F, Tseng Y-K, Wand J-L: Joint modeling of survival and longitudinal data: Likelihood approach revisited. Biometrics 62:1037-1043, 2006
29. Brady MJ, Cella DF, Mo F, et al: Reliability and validity of the Functional Assessment of Cancer Therapy-Breast (FACT-B) quality of life instrument. J Clin Oncol 15:974-986, 1997 (Pubitemid 27106280)
30. Horowitz JL: Semiparametric estimation of a proportional hazard model with unobserved heterogeneity. Econometrica 67:1001-1028, 1999
31. Abbring JH, Van den Berg GJ: The unobserved heterogeneity distribution in duration analysis. Biometrika 94:87-99, 2007